Skip to content
Screener

Organogenesis Holdings Inc. ORGO Accretion To Redemption Value And Cumulative Dividends On Redeemable Convertible Preferred Stock

Accretion To Redemption Value And Cumulative Dividends On Redeemable Convertible Preferred Stock at other companies

EquipmentShare.com, Inc. logo
EquipmentShare.com, Inc.EQPT
$11M0.0%
flyExclusive logo
flyExclusiveFLYX
$58.22M+16.3%
Comtech Telecommunications logo
Comtech TelecommunicationsCMTL
$10.81M-75.7%
SVC
Stellar V Capital Corp.SVCC
$1.38M-88.6%
CEP
Cantor Equity Partners I, Inc.CEPO
$1.86M-78.7%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$0—

Other financials

Income statement

See full
Revenue$43.8M-56.7%
Gross profit$63.0M-22.5%
Operating income-$51.0M-305%
Net income-$96.3M-925%
EPS (diluted)-$0.77-670%

Balance sheet

See full
Cash & equivalents$46.1M-36.9%
Total debt$36.6M+19.2%
Total equity$148.3M-36.4%
Total assets$406.4M-11.9%

Cash flow

See full
Operating cash flow-$31.7M+3.7%
CapEx$1.1M-69.8%
Free cash flow-$32.8M+10.3%

Valuation

See full
Market cap$310.11M-45.7%
Enterprise value$300.57M-43.1%
P/S0.7×-0.7×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin-7.8%—
Net margin-18.4%-20.8pp
FCF margin6.9%—

Returns & leverage

See full
Return on equity-44.1%-48.0pp
Debt / equity0.2×+0.1×
Current ratio3.5×-0.4×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept orgo:AccretionToRedemptionValueAndCumulativeDividendsOnRedeemableConvertiblePreferredStock.

The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338049

FAQ

What is Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock?
Organogenesis Holdings Inc. (ORGO) reported accretion to redemption value and cumulative dividends on redeemable convertible preferred stock of $3.07M in Q2 2026.
How has Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock changed year-over-year?
Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock increased by 9.3% year-over-year, from $2.81M to $3.07M.
What does accretion to redemption value and cumulative dividends on redeemable convertible preferred stock mean?
Accretion To Redemption Value And Cumulative Dividends On Redeemable Convertible Preferred Stock as reported by Organogenesis Holdings Inc. Class A Common Stock.

Ask your AI about Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude